A novel series of arylpiperazines with high affinity and selectivity for the dopamine D3 receptor
- 1 February 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (3) , 219-222
- https://doi.org/10.1016/0960-894x(95)00011-h
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A New Arylpiperazine Antipsychotic with High D2/D3/5-HT1A/.alpha.1A-Adrenergic Affinity and a Low Potential for Extrapyramidal EffectsJournal of Medicinal Chemistry, 1994
- Synthesis and biological activity of C-5 modified derivatives of (+)-AJ76 and (+)-UH232: Increased dopamine D3 receptor preference and improved pharmacokinetic propertiesBioorganic & Medicinal Chemistry Letters, 1994
- Dopamine D3 Receptor: Basic and Clinical AspectsClinical Neuropharmacology, 1993
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- The third dopamine receptor (D3) as a novel target for antipsychoticsBiochemical Pharmacology, 1992
- Molecular biology of the dopamine receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976